Find clinical trials for Diabetes in Barcelona, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus

Type 2 Diabetes Mellitus

Type 1 Diabetes Mellitus

Diabetic Foot

Foot Ulcer

Obesity

Ulcer

Diabetes trials near Barcelona, CT, ESP:

A Phase III Study to Investigate If the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed with Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling

Type 1 Diabetes Mellitus

Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®

Biological: Placebo

Phase 3

Diamyd Medical

Barcelona, Spain and 59 other locations

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting

Diabetic Cardiomyopathies

Drug: AT-001

Drug: Placebo

Phase 3

Applied Therapeutics

Barcelona, Spain and 78 other locations

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting

Diabetes Mellitus, Type 2

Drug: Semaglutide

Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk

Barcelona, Spain and 177 other locations

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Enrolling

Diabetes Mellitus, Type 2

Diabetic Peripheral Neuropathy

Drug: CagriSema (Cagrilintide B and Semaglutide I)

Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk

Barcelona, Spain and 46 other locations

A Study of TCD601 (siplizumab) in New Onset Type 1 Diabetes Patients (STRIDE)

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes...

Active, not recruiting

Diabetes Mellitus, Type 1

Other: Placebo

Biological: TCD601

Phase 2

ITBMed

Barcelona, Spain and 26 other locations

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Enrolling

Diabetes Mellitus, Type 2

Drug: AZD5004

Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca

Barcelona, Spain and 119 other locations

A Pivotal Clinical Investigation Confirming the Safety and Accuracy of the Glyconics-DS in Assessment of Glycated Nail Keratin in Individuals With Unknown Diabetes Status and Performance Evaluation of the Glyconics SW Package (ANODE03)

medical purpose population, i.e., in individuals with unknown diabetes risk. Additionally, this investigation will serve as a pivotal perfor...

Active, not recruiting

Pre-diabetes

Undiagnosed Diseases

Device: Near-infrared (NIR)

Glyconics

Barcelona, Spain

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which cannot be prescribed by doct...

Enrolling

Type 2 Diabetes (T2D)

Drug: Placebo (NNC0487-0111 oral)

Drug: NNC0487-0111 oral

Phase 2

Novo Nordisk

Barcelona, Spain and 103 other locations

A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes

The study medicine will be investigated in participants with type 2 diabetes. Participants will either get insulin icodec or insulin glargin...

Active, not recruiting

Diabetes, Type 2

Drug: Insulin glargine

Drug: Insulin icodec

Phase 3

Novo Nordisk

Barcelona, Spain and 69 other locations

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

to a higher dose of insulin glargine in participants with type 2 diabetes. The study looks at how well the study medicines control blood glu...

Active, not recruiting

Diabetes Mellitus, Type 2

Obesity

Drug: Insuline glargine U100 (titrated)

Drug: Insuline glargine U100 (reduced)

Phase 3

Novo Nordisk

La Roca del Vallés, Spain and 114 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Diabetes in .css-epvm6{white-space:nowrap;}Barcelona, CT

Related conditions:

Diabetes trials near Barcelona, CT, ESP:

A Phase III Study to Investigate If the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed with Type 1 Diabetes (DIAGNODE-3)

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

A Study of TCD601 (siplizumab) in New Onset Type 1 Diabetes Patients (STRIDE)

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

A Pivotal Clinical Investigation Confirming the Safety and Accuracy of the Glyconics-DS in Assessment of Glycated Nail Keratin in Individuals With Unknown Diabetes Status and Performance Evaluation of the Glyconics SW Package (ANODE03)

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

Find clinical trials for Diabetes in Barcelona, CT